Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.19 USD | -4.28% | +1.70% | -12.07% |
May. 14 | Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating | MT |
May. 13 | Transcript : UroGen Pharma Ltd., Q1 2024 Earnings Call, May 13, 2024 |
Financials (USD)
Sales 2024 * | 93.99M | Sales 2025 * | 149M | Capitalization | 477M |
---|---|---|---|---|---|
Net income 2024 * | -128M | Net income 2025 * | -108M | EV / Sales 2024 * | 4.14 x |
Net cash position 2024 * | 88.52M | Net cash position 2025 * | 308M | EV / Sales 2025 * | 1.13 x |
P/E ratio 2024 * |
-3.67
x | P/E ratio 2025 * |
-4.48
x | Employees | 204 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.28% |
Latest transcript on UroGen Pharma Ltd.
1 day | -4.28% | ||
1 week | +1.70% | ||
Current month | -4.56% | ||
1 month | -8.97% | ||
3 months | -31.76% | ||
6 months | +10.01% | ||
Current year | -12.07% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 19-01-02 | |
Dong Kim
DFI | Director of Finance/CFO | 47 | 21-07-31 |
Jason Smith
CMP | Compliance Officer | 52 | 20-09-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arie Belldegrun
CHM | Chairman | 74 | 12-09-30 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 17-09-30 |
Fred Cohen
BRD | Director/Board Member | 67 | 17-05-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +4.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 13.21 | -4.14% | 207,409 |
24-05-15 | 13.78 | +6.25% | 619,719 |
24-05-14 | 12.97 | -0.77% | 481,646 |
24-05-13 | 13.07 | +2.59% | 572,307 |
24-05-10 | 12.74 | -1.77% | 351,013 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.07% | 477M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.73% | 22.28B | |
-11.90% | 22.41B | |
-5.52% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- URGN Stock